Screener
GeneDx Holdings WGS Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by GeneDx Holdings in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: GeneDx Holdings’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001818331-26-000041
| Line item | Three months ended March 31, 2026 | Three months ended March 31, 2025 |
|---|---|---|
| Inventory | 1,689 | (2,032) |
| Accounts payable and accrued expenses | (13,168) | 10,824 |
| Other assets and liabilities | (9,125) | 3,116 |
| Net cash (used in) provided by operating activities | (32,408) | 10,182 |
| Investing activities | ||
| Purchases of marketable securities | (20,177) | (17,209) |
| Proceeds from sales of marketable securities | 875 | — |
| Proceeds from maturities of marketable securities | 8,500 | 13,930 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is GeneDx Holdings's operating cash flow?
- GeneDx Holdings (WGS) reported operating cash flow of -$32.41M in Q1 2026.
- How has GeneDx Holdings's operating cash flow changed year-over-year?
- GeneDx Holdings's operating cash flow decreased by 418.3% year-over-year, from $10.18M to -$32.41M.
- What is the long-term trend for GeneDx Holdings's operating cash flow?
- Over 4 years (2021 to 2025), GeneDx Holdings's operating cash flow has grown at a -33.9% compound annual growth rate (CAGR), from -$190.43M to $36.37M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about GeneDx Holdings's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude